DRKS00024724招募中不适用
TriMaximize: A multicentre, prospective, non-interventional trial monitoring therapy pathways of Asthma patients treated with an extra-fine ICS/LABA/LAMA single-inhaler triple therapy in a real-world setting and characterizing the effects on health-related outcomes - TriMaximize
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Chiesi GmbH
- 入组人数
- 3,950
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1) Patients = 18 years of age,
- •2) Patients with confirmed leading diagnosis of asthma with or without concomitant COPD,
- •3) Physician decision to start fixed triple therapy with ICS/LABA/LAMA (Trimbow® MS or HS) according to its current authorised indication. The treatment decision must be made independently from participation in
- •4) Patients willing and able to sign an informed consent for use of their pseudonymised clinical data within the present non-interventional
排除标准
- •1) Participation in an interventional clinical trial within 30 days prior to enrolment into the present non-interventional study or planned enrolment in an interventional clinical trial during the observational period.
- •No further selection criteria apply, in order to enrol a population that is likely to
- •reflect the current target population for ICS/LABA/LAMA combination therapy as per routine clinical practice.
研究者
相似试验
已完成
不适用
TriOptimize: A prospective non-interventional Trial on COPD patients’ health related quality of life under a fixed LAMA/LABA/ICS triple therapy and characterization of determinants of treatment adherenceAsthmaJ44.9J45Chronic obstructive pulmonary disease, unspecifiedDRKS00013938Chiesi GmbH2,623
进行中（未招募）
1 期
Clinical trial for the relapsed Osteosarcoma treatmentEUCTR2015-004762-28-ITITALIAN SARCOMA GROUP100
进行中（未招募）
3 期
A Phase III b study to evaluate P1101 in Japanese PV patientsPolycythemia VeraJPRN-jRCT2031230267Kawase Hiroaki20
进行中（未招募）
不适用
Propranololtherapy in infants and toddlers with severe hemangiomaHemangioma in infants and toddlers, requiring systemic therapyMedDRA version: 13.1Level: LLTClassification code 10019386Term: HemangiomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-019754-41-DEInfectoPharm Arzneimittel und Consilium GmbH
招募中
不适用
TriMaximize: A Multicentre, Prospective, Non-interventional Trial in Asthma PatientsAsthmaNCT06567977Chiesi Poland Sp. z o.o.60